{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:13:05Z","timestamp":1794881585293,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T00:00:00Z","timestamp":1306454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1208\/s12248-011-9282-9","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T17:21:43Z","timestamp":1306430503000},"page":"390-404","source":"Crossref","is-referenced-by-count":34,"title":["Development of a Complex Parent-Metabolite Joint Population Pharmacokinetic Model"],"prefix":"10.1208","volume":"13","author":[{"given":"Julie","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line M.","family":"Laffont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Mentr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylore","family":"Chenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Comets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,27]]},"reference":[{"key":"9282_CR1","volume-title":"Applied biopharmaceutics & pharmacokinetics","author":"L Shargel","year":"2005","unstructured":"Shargel L, Wu-Pong S, Yu A. Applied biopharmaceutics & pharmacokinetics. 5th ed. USA: McGraw-Hill Medical; 2005.","edition":"5"},{"key":"9282_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00280-008-0769-8","volume":"63","author":"IR Younis","year":"2009","unstructured":"Younis IR, Malone S, Friedman HS, Schaaf LJ, Petros WP. Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma. Cancer Chemother Pharmacol. 2009;63:517\u201324.","journal-title":"Cancer Chemother Pharmacol"},{"key":"9282_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2125.2005.02456.x","volume":"60","author":"X Panhard","year":"2005","unstructured":"Panhard X, Goujard C, Legrand M, Taburet AM, Diquet B, Mentr\u00e9 F. Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART. Br J Clin Pharmacol. 2005;60:390\u2013403.","journal-title":"Br J Clin Pharmacol"},{"key":"9282_CR4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03276.x","volume":"66","author":"Y Feng","year":"2008","unstructured":"Feng Y, Pollock BG, Coley K, Marder S, Miller D, Kirshner M, et al. Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study. Br J Clin Pharmacol. 2008;66:629\u201339.","journal-title":"Br J Clin Pharmacol"},{"key":"9282_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2307\/2532087","volume":"46","author":"M Lindstrom","year":"1990","unstructured":"Lindstrom M, Bates D. Nonlinear mixed effects models for repeated measures data. Biometrics. 1990;46:673\u201387.","journal-title":"Biometrics"},{"key":"9282_CR6","unstructured":"Beal S, Sheiner L, Boeckmann A, Bauer R. NONMEM user's guides (1989\u20132009). Ellicott City, MD, USA; 2009"},{"key":"9282_CR7","unstructured":"Girard P, Mentr\u00e9 F. A comparison of estimation methods in nonlinear mixed effects models using a blind analysis. Pamplona, Spain: 14th Population Approach Group in Europe; 2005. Available from: http:\/\/www.page-meeting.org\/page\/page2005\/PAGE2005O08.pdf ."},{"key":"9282_CR8","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/10543400802369012","volume":"18","author":"J Bertrand","year":"2008","unstructured":"Bertrand J, Comets E, Mentr\u00e9 F. Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters. J Biopharm Stat. 2008;18:1084\u2013102.","journal-title":"J Biopharm Stat"},{"key":"9282_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.csda.2004.07.002","volume":"49","author":"E Kuhn","year":"2005","unstructured":"Kuhn E, Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. Comput Stat Data Anal. 2005;49:1020\u201338.","journal-title":"Comput Stat Data Anal"},{"key":"9282_CR10","unstructured":"Lavielle M. MONOLIX (MOd\u00e8les NOn LIn\u00e9aires \u00e0 effets miXtes). Orsay, France; 2008. http:\/\/software.monolix.org\/index.php ."},{"key":"9282_CR11","unstructured":"Bauer RJ. S-ADAPT\/MCPEM User's Guide Version 1.56. Los Angeles, CA, USA; 2008."},{"key":"9282_CR12","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1124\/jpet.107.134536","volume":"324","author":"MJ Millan","year":"2008","unstructured":"Millan MJ, Loiseau F, Dekeyne A, Gobert A, Flik G, Cremers TI, et al. S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3\u00a0H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects. J Pharmacol Exp Ther. 2008;324:1212\u201326.","journal-title":"J Pharmacol Exp Ther"},{"key":"9282_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/03602530902843483","volume":"41","author":"S Zhou","year":"2009","unstructured":"Zhou S, Liu J, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41:89\u2013295.","journal-title":"Drug Metab Rev"},{"key":"9282_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10928-009-9124-x","volume":"36","author":"J Bertrand","year":"2009","unstructured":"Bertrand J, Comets E, Laffont C, Chenel M, Mentr\u00e9 F. Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm. J Pharmacokinet Pharmacodyn. 2009;36:317\u201339.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9282_CR15","volume-title":"Randomization, bootstrap and Monte Carlo methods in biology","author":"B Manly","year":"1998","unstructured":"Manly B. Randomization, bootstrap and Monte Carlo methods in biology. 2nd ed. London: Chapman & Hall; 1998.","edition":"2"},{"key":"9282_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/00003088-200746030-00003","volume":"46","author":"K Brendel","year":"2007","unstructured":"Brendel K, Dartois C, Comets E, Lemenuel-Diot A, Laveille C, Tranchand B, et al. Are population pharmacokinetic and\/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004. Clin Pharmacokinet. 2007;46:221\u201334.","journal-title":"Clin Pharmacokinet"},{"key":"9282_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1365-2125.2008.03110.x","volume":"65","author":"B Hamr\u00e9n","year":"2008","unstructured":"Hamr\u00e9n B, Ericsson H, Samuelsson O, Karlsson M. Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function-evidence of interconversion. Br J Clin Pharmacol. 2008;65:855\u201363.","journal-title":"Br J Clin Pharmacol"},{"key":"9282_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/bdd.2510140902","volume":"14","author":"H Cheng","year":"1993","unstructured":"Cheng H, Jusko W. Pharmacokinetics of reversible metabolic systems. Biopharm Drug Dispos. 1993;14:721\u201366.","journal-title":"Biopharm Drug Dispos"},{"key":"9282_CR19","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker; 1982.","edition":"2"},{"key":"9282_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00561564","volume":"8","author":"D Vaughan","year":"1975","unstructured":"Vaughan D, Mallard D, Trainor A, Mitchard M. General pharmacokinetic equations for linear mammillary models with drug absorption into peripheral compartments. Europ J Clin Pharmacol. 1975;8:141\u20138.","journal-title":"Europ J Clin Pharmacol"},{"key":"9282_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"G Schwartz","year":"1978","unstructured":"Schwartz G. Estimating the dimension of a model. Ann Stat. 1978;6:461\u20134.","journal-title":"Ann Stat"},{"key":"9282_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1198\/tast.2009.08196","volume":"63","author":"C Faes","year":"2009","unstructured":"Faes C, Molenberghs G, Aerts M, Verbeke G, Kenward MG. The effective sample size and an alternative small-sample degrees-of-freedom method. Am Stat. 2009;63:389\u201399.","journal-title":"Am Stat"},{"key":"9282_CR23","unstructured":"Visser I, Ray S, Jang W, Berger J. Effective sample size and the Bayes factor. Research Triangle Park, NC: workshop on latent variable modeling in social sciences, SAMSI; 2006."},{"issue":"4","key":"9282_CR24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2307\/2533455","volume":"50","author":"DO Stram","year":"1994","unstructured":"Stram DO, Lee JW. Variance components testing in the longitudinal mixed effects model. Biometrics. 1994;50(4):1171\u20131177. Available from: http:\/\/www.jstor.org\/stable\/2533455 .","journal-title":"Biometrics"},{"key":"9282_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1373\/49.4.542","volume":"49","author":"W Chou","year":"2003","unstructured":"Chou W, Yan F, Robbins-Weilert D, Ryder T, Liu W, Perbost C, et al. Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships. Clin Chem. 2003;49:542\u201351.","journal-title":"Clin Chem"},{"key":"9282_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00008571-200007000-00001","volume":"10","author":"V Ozdemir","year":"2000","unstructured":"Ozdemir V, Kalow W, Tang B, Paterson A, Walker S, Endrenyi L, et al. Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics. 2000;10:373\u201388.","journal-title":"Pharmacogenetics"},{"key":"9282_CR27","unstructured":"Karlsson M, Holford N. A Tutorial on visual predictive checks. Marseille, France: 17th Population Approach Group in Europe; 2008. Available from: http:\/\/www.page-meeting.org\/pdf\\_assets\/8694-Karlsson\\_Holford\\_VPC\\_Tutorial\\_hires.pdf ."},{"key":"9282_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10928-009-9143-7","volume":"37","author":"K Brendel","year":"2010","unstructured":"Brendel K, Comets E, Laffont C, Mentr\u00e9 F. Evaluation of different tests based on observations for external model evaluation of population analyses. J Pharmacokinet Pharmacodyn. 2010;37:49\u201365.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9282_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets E, Brendel K, Mentr\u00e9 F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Programs Biomed. 2008;90:154\u201366.","journal-title":"Comput Methods Programs Biomed"},{"key":"9282_CR30","volume-title":"Clinical pharmacokinetics. Concepts and applications","author":"M Rowland","year":"1995","unstructured":"Rowland M, Tozer T. Clinical pharmacokinetics. Concepts and applications. 3rd ed. USA: Lippincot Williams & Wilkins; 1995.","edition":"3"},{"key":"9282_CR31","first-page":"40","volume":"25","author":"S Martin","year":"1997","unstructured":"Martin S, Bishop F, Kerr B, Moor M, Moore M, Sheffels P, et al. Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans. Drug Metab Dispos. 1997;25:40\u20136.","journal-title":"Drug Metab Dispos"},{"key":"9282_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0928-0987(00)00086-5","volume":"10","author":"S Duffull","year":"2000","unstructured":"Duffull S, Chabaud S, Nony P, Laveille C, Girard P, Aarons L. A pharmacokinetic simulation model for ivabradine in healthy volunteers. Eur J Pharm Sci. 2000;10:285\u201394.","journal-title":"Eur J Pharm Sci"},{"key":"9282_CR33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1211\/jpp.58.7.0001","volume":"58","author":"M Murray","year":"2006","unstructured":"Murray M. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. J Pharm Pharmacol. 2006;58:871\u201385.","journal-title":"J Pharm Pharmacol"},{"key":"9282_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/JCP.0b013e3181a289e0","volume":"29","author":"R Kang","year":"2009","unstructured":"Kang R, Jung S, Kim K, Lee D, Cho H, Jung B, et al. Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients. J Clin Psychopharmacol. 2009;29:272\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"9282_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/clpt.1992.38","volume":"51","author":"L Bertilsson","year":"1992","unstructured":"Bertilsson L, Lou Y, Du Y, Liu Y, Kuang T, Liao X, et al. Pronounced differences betweennative Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin andS-mephenytoin. Clin Pharmacol Ther. 1992;51:388\u201397.","journal-title":"Clin Pharmacol Ther"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-011-9282-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-011-9282-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-011-9282-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-011-9282-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T05:27:09Z","timestamp":1712467629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-011-9282-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,27]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9282"],"URL":"https:\/\/doi.org\/10.1208\/s12248-011-9282-9","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,27]]}}}